Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Cytokine Network

• Publication date

  2010-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1684/ecn.2009.0177PMID 20146992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Effects of Insulin and Free Fatty Acids on Matrix Metalloproteinases in Rat Aorta

  2008cited by this paper
• Macrophages regulate tumor necrosis factor-α expression in adipocytes through the secretion of matrix metalloproteinase-3

  2008cited by this paper
• A functional role of gelatinase A in the development of nutritionally induced obesity in mice

  2008cited by this paper
• Surgical treatment of obesity.

  2008cited by this paper
• Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms

  2008cited by this paper
• Gene expression in human NAFLD.

  2008cited by this paper
• Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease.

  2008cited by this paper
• Matrix metalloproteinase-2 and -9 levels in obese patients.

  2008cited by this paper
• Pathology of nonalcoholic fatty liver disease.

  2007cited by this paper
• Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans.

  2007cited by this paper
• Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome

  2007cited by this paper
• Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.

  2007cited by this paper
• Long-term mortality after gastric bypass surgery.

  2007cited by this paper
• Pathology of nonalcoholic fatty liver disease

  2007cited by this paper
• Gastric Bypass Surgery Improves Metabolic and Hepatic Abnormalities Associated With Nonalcoholic Fatty Liver Disease

  2007cited by this paper
• Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.

  2006cited by this paper
• Differential Expression of Matrix Metalloproteinase 3 (MMP3) in Preadipocytes/Stromal Vascular Cells From Nonobese Nondiabetic Versus Obese Nondiabetic Pima Indians

  2006cited by this paper
• Structure and function of matrix metalloproteinases and TIMPs.

  2006cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Matrix metalloproteinases in development and disease.

  2006cited by this paper
• Abdominal obesity and metabolic syndrome

  2006cited by this paper
• Inhibition of matrix metalloproteinases increases PPAR- (cid:1) and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model

  2006cited by this paper
• Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4.

  2006cited by this paper
• Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development

  2006cited by this paper
• Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

  2006cited by this paper
• Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

  2005cited by this paper
• Protease Inhibitor Treatments Reveal Specific Involvement of Matrix Metalloproteinase-9 in Human Adipocyte Differentiation

  2005cited by this paper
• Effect of matrix metalloproteinase inhibition on adipose tissue development.

  2005cited by this paper
• Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women

  2005cited by this paper
• Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

  2004cited by this paper
• Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization

  2004cited by this paper
• Matrix Metalloproteinases Are Differentially Expressed in Adipose Tissue during Obesity and Modulate Adipocyte Differentiation*

  2003influential reference
• Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice

  2003cited by this paper
• Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity.

  2002cited by this paper
• Adipocyte Hypertrophy in Stromelysin-3 Deficient Mice with Nutritionally Induced Obesity

  2002cited by this paper
• Ultrasound Measurement of Visceral and Subcutaneous Fat in Morbidly Obese Patients Before and after Laparoscopic Adjustable Gastric Banding: Comparison with Computerized Tomography and with Anthropometric Measurements

  2002cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• Surgical treatment of obesity.

  1989cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options.

  2024cites this paper
• Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions

  2023cites this paper
• Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease

  2023cites this paper
• Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids – A Double Blind, Randomised Clinical Trial

  2022cites this paper
• Preservation of fat-free mass in the first year after bariatric surgery: a systematic review and meta-analysis of 122 studies and 10,758 participants.

  2022cites this paper
• Circulating adipose tissue proteins involved in atrial fibrillation: an explorative scoping review.

  2022cites this paper
• Pathophysiology of metalloproteinase matrix in relation to morbid obesity and associated pathologies

  2022cites this paper
• Regulation of the gut barrier by carbohydrates from diet - Underlying mechanisms and possible clinical implications.

  2021cites this paper
• M1 Polarized Macrophages Persist in Skin of Post-Bariatric Patients after 2 Years

  2021cites this paper
• MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity

  2021cites this paper
• How Does Fat Mass Change in the First Year After Bariatric Surgery? A Systemic Review and Meta-Analysis

  2021influential citation
• Peptide decorated gold nanoparticle/carbon nanotube electrochemical sensor for ultrasensitive detection of matrix metalloproteinase-7

  2020cites this paper
• Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

  2020cites this paper
• Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?

  2020cites this paper
• Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity

  2019cites this paper
• Nutrition, epigenetics and health through life

  2017cites this paper
• Inflection Point of the Localized Surface Plasmon Resonance Peak: A General Method to Improve the Sensitivity.

  2017cites this paper
• Does Bariatric Surgery Improve Obesity Associated Comorbid Conditions.

  2017cites this paper
• Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population

  2017cites this paper
• Extracellular matrix remodeling and matrix metalloproteinase inhibition in visceral adipose during weight cycling in mice

  2017cites this paper
• The Important Roles of Matrix Metalloproteinases in the Pathophysiology of Obesity

  2017cites this paper
• Matrix Metalloproteinases in Non-Neoplastic Disorders

  2016cites this paper
• Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice

  2016cites this paper
• Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced

  2015cites this paper
• Matrix metalloproteases as a pharmacological target in cardiovascular diseases.

  2015cites this paper
• Insights on Adipose Tissue Extracellular Matrix Remodeling: Models of Diet-Induced Obesity and Weight Loss

  2015cites this paper
• Serum SPARC and Matrix Metalloproteinase-2 and Metalloproteinase-9 Concentrations after Bariatric Surgery in Obese Adults

  2014cites this paper
• Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity.

  2014cites this paper
• Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue

  2013cites this paper
• Peptide functionalized gold nanoparticles for colorimetric detection of matrilysin (MMP-7) activity.

  2013cites this paper
• Differential Proinflammatory and Oxidative Stress Response and Vulnerability to Metabolic Syndrome in Habitual High-Fat Young Male Consumers Putatively Predisposed by Their Genetic Background

  2013cites this paper
• Ubiquitin‐specific protease 2‐69 in macrophages potentially modulates metainflammation

  2013cites this paper
• Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes

  2012cites this paper
• Matrix metalloproteinases in metabolic syndrome.

  2012cites this paper
• Receptor activator of NF-κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability

  2011cites this paper
• Effect of weight loss on gelatinase levels in obese mice

  2011cites this paper